US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...

MANCHESTER, UNITED KINGDOM, March 10, 2026 /EINPresswire.com/ -- Monument Therapeutics, a stratified medicine company, ...

UCSF researcher Daniel Mathalon, MD, PhD, believes that burgeoning knowledge about biomarkers — biological measures of a ...

PsyMetRiC is designed to be simple and easy to use in clinical practice, and requires only simple, routinely-recorded ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Keith Sakata said he has seen 12 patients hospitalized in 2025 after experiencing "AI psychosis." He works in San Francisco ...

Denmark: A study published in Diabetes Care has revealed that semaglutide improves insulin sensitivity in patients with schizophrenia who have prediabetes and are overweight or obese. The ...

For over a hundred years, the specter of a schizophrenia diagnosis has frightened patients and their families. Yet it confers ...

Northville’s new state psychiatric hospital is on track for fall patient moves, but audits and staffing plans remain under ...

Khan, S. and Issa, H. (2026) Uncontrolled Hypothyroidism with Antiphospholipid Syndrome Resulting in Myxedema Psychosis. Open Journal of Psychiatry, 16, 131-138. doi: 10.4236/ojpsych.2026.162010 .

Cambridge Cognition (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care, reports that ...

A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic ...